^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PancAlert

    Company:
    Mainz BioMed
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    PancAlert, its screening test candidate for pancreatic cancer has achieved multiple pre-clinical milestones that support the development of this potential first-in-class diagnostic for a deadly cancer indication.
    Cancer:
    Pancreatic Cancer
    Method:
    Next-Generation Sequencing